AusPAR: Upadacitinib
Australian Public Assessment Report
Device/Product Name
Rinvoq
Active ingredients
Upadacitinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-02479-1-3
Submission Type
Extension of indications
Decision
Approved